Versantis is a developer of liver disease therapeutics and diagnostics intended to provide the first drug capture platform for the treatment of life-threatening intoxications. The company's pharmaceutical services offer novel antidotes, that focus on treatment for acute-on-chronic liver failure (ACLF), support the affected organs (liver, kidneys, brain) and encourage liver regeneration, enabling ACLF patients to receive life-saving therapies.